The Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award (CTSA) consortium, led by the
National Institutes of HealthNational Center for Advancing Translational Sciences (NCATS). Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,300 members. The ACTRI News and Funding Opportunities is a monthly newsletter.
Director’s Message, Spring 2017
I am pleased to announce our participation in two new NIH initiatives that create nationwide networks to support critical facets of clinical trials: The Trial Innovation Network (TIN) and the Accrual to Clinical Trials program (ACT). UC San Diego Altman Clinical and Translational Research Institute (ACTRI) serves as the local link to these exciting new efforts. The goal of the TIN is to provide consultation and services for the design and initiation of new multi-center clinical trials, while ACT provides new tools for assessing study feasibility. The Trial Innovation Network is a rapidly developing collaborative initiative of the NIH Clinical and Translational Science Awards (CTSA) Program that leverages the expertise, skills, and knowledge of the CTSA Consortium.
NEW!!ACTRI Invites Applications for 2018 Pilot Project Awards
Deadline (First Stage): July 21, 2017
ACTRI Vouchers for ACTRI Research Services (In-kind)
- Allowance for Vouchers to Supplement Two Types of NIH-Funded Studies for ACTRI Clinical Services Only
- Recent Addition of CCBB Vouchers
Eligible: Unfunded Projects Designed to Gather Preliminary Data for Grant Submissions or ACTRI Pilot Projects, Career Development Awards (K-series only; UC San Diego only) and ACTRI KL2 Awardees. In addition, Vouchers can potentially be used to supplement two types of NIH-funded studies for ACTRI clinical services only.
NCATS Open Funding Opportunities
NEW** OptumLabs Seeks Volunteers for Diabetes Stakeholder Working Group
ACTRI News and Features
ACTRI Center for Life Course Research leaders at the childhood adversity symposium are (from left): Dilip Jeste, MD; Gretchen Bandoli, PhD; Christina Chambers, PhD, MPH; Linda McEvoy, PhD; and Andrea LaCroix, PhD.
ACTRI Symposium Explores Impacts of Adverse Childhood Experiences
Maltreatment and trauma during childhood have deep and enduring effects, concluded presenters at the “Adverse Childhood Experiences: Consequences Across the Life Course” symposium. The Center for Life Course Research at UC San Diego Altman Clinical and Translational Research Institute (ACTRI) presented the symposium on May 17, drawing about 150 participants. “It is critical to study the impacts of adverse childhood experiences on health across the life course,” said Christina Chambers, PhD, MPH, a professor of pediatrics and epidemiology at UC San Diego and director of the ACTRI Center for Life Course Research. “We were pleased to present a symposium that brought together a distinguished and varied group of presenters to address multiple areas related to this topic. Through continued studies, we hope to develop measures for prevention.” Chambers co-directed the event with Dilip Jeste, MD, who also presented a talk, “Longer-term Effects of Childhood Adversity in People With and Without Serious Mental Illnesses.”
ACTRI Announces 2017 KL2 Recipients
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) recently selected three new KL2 awardees for 2017. The awardees are (from left in photos above): Aaron Carlin, MD; Robert A Dorschner, MD; and Andrew Sharabi, MD, PhD. All three are from UC San Diego. As part of the ACTRI Education program, KL2 awards provide a tailored mentored research experience to promising faculty clinical and translational researchers.
In This Issue
ACTRI Seminar Series
September, 2017, Date to be Announced—“Cardiac Rehabilitation: Current and Future Directions,” will be presented by Pam R. Taub, MD, FACC, director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center, and Associate Professor of Medicine, University of California San Diego, in September at the Altman Clinical and Translational Research Institute Building, first floor Auditorium.
Cite the Grant
Don’t forget to cite the grant!
To help ensure resources are available for future research,
please cite the UCSD ACTRI CTSA grant.
Projects and Publications using UCSD ACTRI resources must cite the UCSD ACTRI grant and follow the NIH Public Access Policy.
ACTRI News and Funding Opportunities
Gary S. Firestein, MD
Director of ACTRI
Chief Administrative Officer